David Malcom Rodman, the Chief Medical Officer of $MLYS, sold 2,171 shares of the company on 07-09-2026 for an estimated $65,781. We received data on the trade from a recent SEC filing. This was a sale of approximately 3.6% of their shares of this class of stock. Following this trade, they now own 57,733 shares of this class of $MLYS stock.
$MLYS Insider Trading Activity
$MLYS insiders have traded $MLYS stock on the open market 45 times in the past 6 months. Of those trades, 2 have been purchases and 43 have been sales.
Here’s a breakdown of recent trading of $MLYS stock by insiders over the last 6 months:
- CAPITAL MANAGEMENT, L.P. RA has made 2 purchases buying 369,000 shares for an estimated $8,762,797 and 0 sales.
- JON CONGLETON (Chief Executive Officer) has made 0 purchases and 8 sales selling 181,966 shares for an estimated $4,882,742.
- DAVID MALCOM RODMAN (Chief Medical Officer) has made 0 purchases and 31 sales selling 145,144 shares for an estimated $4,079,912.
- ERIC WARREN (Chief Commercial Officer) sold 104,124 shares for an estimated $2,696,322
- ADAM SCOTT LEVY (CFO and Secretary) sold 10,758 shares for an estimated $345,723
- DAPHNE KARYDAS has made 0 purchases and 2 sales selling 6,000 shares for an estimated $150,000.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$MLYS Hedge Fund Activity
We have seen 109 institutional investors add shares of $MLYS stock to their portfolio, and 81 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP added 2,574,801 shares (+328.3%) to their portfolio in Q1 2026, for an estimated $69,751,359
- HOLOCENE ADVISORS, LP removed 1,602,035 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $43,399,128
- SAMLYN CAPITAL, LLC removed 1,304,932 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $35,350,607
- CAPITAL INTERNATIONAL INVESTORS removed 1,163,290 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $31,513,526
- ORBIMED ADVISORS LLC added 1,072,500 shares (+109.4%) to their portfolio in Q1 2026, for an estimated $29,054,025
- SPHERA FUNDS MANAGEMENT LTD. added 890,968 shares (+198.4%) to their portfolio in Q1 2026, for an estimated $24,136,323
- FARALLON CAPITAL MANAGEMENT LLC removed 823,296 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $22,303,088
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$MLYS Analyst Ratings
Wall Street analysts have issued reports on $MLYS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- TD Cowen issued a "Buy" rating on 04/27/2026
To track analyst ratings and price targets for $MLYS, check out Quiver Quantitative's $MLYS forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
